BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25842146)

  • 1. Nanostructured delivery system for Suberoylanilide hydroxamic acid against lung cancer cells.
    Sankar R; Karthik S; Subramanian N; Krishnaswami V; Sonnemann J; Ravikumar V
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():362-8. PubMed ID: 25842146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
    Sankar R; Ravikumar V
    Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
    Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
    J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
    Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
    Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Simvastatin-Loaded Nanoparticles Based on Cholic Acid-Core Star-Shaped PLGA for Breast Cancer Treatment.
    Wu Y; Wang Z; Liu G; Zeng X; Wang X; Gao Y; Jiang L; Shi X; Tao W; Huang L; Mei L
    J Biomed Nanotechnol; 2015 Jul; 11(7):1247-60. PubMed ID: 26307847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
    Liu J; Qiu Z; Wang S; Zhou L; Zhang S
    Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Histone Deacetylase Inhibitor Vorinostat-Loaded Poly D, L-Lactide-co-Glycolide Polymeric Nanoparticles by Nanoprecipitation Method.
    Ravikumar V; Sankar R
    Methods Mol Biol; 2017; 1510():399-403. PubMed ID: 27761838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.
    Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q
    Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of amoxicillin within laponite-doped poly(lactic-co-glycolic acid) nanofibers: preparation, characterization, and antibacterial activity.
    Wang S; Zheng F; Huang Y; Fang Y; Shen M; Zhu M; Shi X
    ACS Appl Mater Interfaces; 2012 Nov; 4(11):6393-401. PubMed ID: 23131186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
    Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
    Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation, cytotoxicity and apoptosis studies of methotrexate-loaded PLGA and PLGA-PEG nanoparticles.
    Afshari M; Derakhshandeh K; Hosseinzadeh L
    J Microencapsul; 2014; 31(3):239-45. PubMed ID: 24124881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
    Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
    J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis.
    Kumar G; Sharma S; Shafiq N; Pandhi P; Khuller GK; Malhotra S
    Drug Deliv; 2011 Jan; 18(1):65-73. PubMed ID: 20735202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
    Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
    J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
    Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.